- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06628960
Effect of Su Jok Therapy on Breastfeeding (Sujok)
The Effect of Su Jok Therapy on Breastfeeding Success, Breastfeeding Self-Efficacy and Perception of Insufficient Milk After Caesarean Section in Primiparous
There are many alternative methods to increase breast milk. In the literature, studies on Su Jok therapy applications are limited and no studies on increasing breast milk have been found. In Korean language, 'Su' means hand and 'Jok' means foot. Su Jok therapy is defined as a modern acupressure/acupuncture interpretation that utilises the body's independent communication systems on the hands and feet by applying various techniques such as massage, moxa (heating), needles, magnets and seeds to the reflection points on the hands and feet. Su Jok is an integrated therapy that incorporates many tried and trusted methods of oriental medicine
Study Overview
Detailed Description
There are many alternative methods to increase breast milk. In the literature, studies on Su Jok therapy applications are limited and no studies on increasing breast milk have been found. In Korean language, 'Su' means hand and 'Jok' means foot. Su Jok therapy is defined as a modern acupressure/acupuncture interpretation that utilises the body's independent communication systems on the hands and feet by applying various techniques such as massage, moxa (heating), needles, magnets and seeds to the reflection points on the hands and feet. Su Jok is an integrated therapy that incorporates many tried and trusted methods of oriental medicine.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Eyalet/Yerleşke
-
Sanliurfa, Eyalet/Yerleşke, Turkey (Türkiye), 63000
- Şanlıurfa training and research hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- primiparous women giving birth by caesarean section,
- women aged 19-35,
- breastfeeding women
Exclusion Criteria:
- those who refused to participate in the research
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: su jok therapy;
su jok therapy; application of seeds placed at certain points on the palm of the hand every day for the first ten days after birth, every day to be kept in the hand for 4 hours. |
Su Jok Therapy |
|
No Intervention: control group
control group, Su Jok will not be applied |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Breastfeeding Self-Efficacy Scale
Time Frame: Pre-test; before the first Su Jok intervention
|
It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
Pre-test; before the first Su Jok intervention
|
|
Breastfeeding Self-Efficacy Scale
Time Frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
|
Breastfeeding Self-Efficacy Scale
Time Frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
It was developed by Dennis (2003). Its Turkish validity and reliability was conducted by Aluş Tokat et al. (2010). The scale consists of 14 items and is in five-point Likert type. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
|
Breastfeeding Charting System: LATCH
Time Frame: Pre-test; before the first Su Jok intervention
|
It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
Pre-test; before the first Su Jok intervention
|
|
Breastfeeding Charting System: LATCH
Time Frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion. A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
|
Breastfeeding Charting System: LATCH
Time Frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
It was developed by Jensen et al. (1994). Its Turkish validity and reliability was performed by Yenal and Okumuş (2003). LATCH includes five evaluation criteria and consists of the first letters of the English equivalents of these criteria. In the LATCH Scoring System, 0, 1 or 2 points are given for each criterion. A minimum score of 0 and a maximum score of 10 can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy. |
On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
|
Inadequate Milk Perception Scale
Time Frame: Pre-test; before the first Su Jok intervention
|
The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency. |
Pre-test; before the first Su Jok intervention
|
|
Inadequate Milk Perception Scale
Time Frame: On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency. |
On the 3rd day after cesarean section (72 hours postpartum), before the 3rd Su Jok intervention.
|
|
Inadequate Milk Perception Scale; before the 3rd Su Jok intervention
Time Frame: On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
The scale developed by McCarter-Spaulding and Kearney in 2001 consists of 6 questions to determine inadequate perception of breast milk. The first question questioning whether the mother perceives her milk as sufficient or not is in the form of 'yes' or 'no'. The other 5 questions aim to measure the perception of inadequacy of milk and are scored between 0-10. '0' indicates that milk is perceived as completely inadequate and "10" indicates that milk is perceived as completely adequate. The scale is scored between 0-50. A high score indicates an increased perception of milk sufficiency. |
On the 10th day after cesarean section; after the last (10th) Su Jok intervention.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: AYŞEGÜL KILIÇLI, Assisstan. Prof. PhD., Muş Alparslan University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MAUN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All
IPD Sharing Time Frame
15 October 2024- 15 October 2025
IPD Sharing Access Criteria
15 October 2024- 15 October 2025
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.